The daily business briefing: March 3, 2021

Merck agrees to help produce Johnson & Johnson coronavirus vaccine, Texas' governor to let businesses fully reopen, and more

The Johnson & Johnson vaccine
(Image credit: Getty Images)

1. Merck to help produce more Johnson & Johnson vaccine

Merck has agreed to produce Johnson & Johnson's single-dose COVID-19 vaccine in a deal expected to boost the nation's inoculation effort, President Biden announced Tuesday. The deal with Merck, a Johnson & Johnson rival, was hammered out in talks between the two companies' chief executives and White House COVID-19 coordinator Jeff Zients. It will help speed up production and distribution of the vaccine, which received emergency approval from regulators on Saturday and added a third vaccine to the U.S. arsenal, along with those produced by Pfizer and Moderna. Biden said the deal was part of a stepped-up effort that was putting the country on track to have enough vaccine for every adult by May.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Harold Maass, The Week US

Harold Maass is a contributing editor at The Week. He has been writing for The Week since the 2001 debut of the U.S. print edition and served as editor of TheWeek.com when it launched in 2008. Harold started his career as a newspaper reporter in South Florida and Haiti. He has previously worked for a variety of news outlets, including The Miami Herald, ABC News and Fox News, and for several years wrote a daily roundup of financial news for The Week and Yahoo Finance.